via Wistar Institute
Wistar Institute scientists have discovered a new class of compounds that uniquely combine direct antibiotic killing of pan drug-resistant bacterial pathogens with a simultaneous rapid immune response for combatting antimicrobial resistance (AMR).
These finding were published today in Nature.
The World Health Organization (WHO) has declared AMR as one of the top 10 global public health threats against humanity. It is estimated that by 2050, antibiotic-resistant infections could claim 10 million lives each year and impose a cumulative $100 trillion burden on the global economy. The list of bacteria that are becoming resistant to treatment with all available antibiotic options is growing and few new drugs are in the pipeline, creating a pressing need for new classes of antibiotics to prevent public health crises.
“We took a creative, double-pronged strategy to develop new molecules that can kill difficult-to-treat infections while enhancing the natural host immune response,” said Farokh Dotiwala, M.B.B.S., Ph.D., assistant professor in the Vaccine & Immunotherapy Center and lead author of the effort to identify a new generation of antimicrobials named dual-acting immuno-antibiotics (DAIAs).
Existing antibiotics target essential bacterial functions, including nucleic acid and protein synthesis, building of the cell membrane, and metabolic pathways. However, bacteria can acquire drug resistance by mutating the bacterial target the antibiotic is directed against, inactivating the drugs or pumping them out.
“We reasoned that harnessing the immune system to simultaneously attack bacteria on two different fronts makes it hard for them to develop resistance,” said Dotiwala.
He and colleagues focused on a metabolic pathway that is essential for most bacteria but absent in humans, making it an ideal target for antibiotic development. This pathway, called methyl-D-erythritol phosphate (MEP) or non-mevalonate pathway, is responsible for biosynthesis of isoprenoids — molecules required for cell survival in most pathogenic bacteria. The lab targeted the IspH enzyme, an essential enzyme in isoprenoid biosynthesis, as a way to block this pathway and kill the microbes. Given the broad presence of IspH in the bacterial world, this approach may target a wide range of bacteria.
Researchers used computer modeling to screen several million commercially available compounds for their ability to bind with the enzyme, and selected the most potent ones that inhibited IspH function as starting points for drug discovery.
Since previously available IspH inhibitors could not penetrate the bacterial cell wall, Dotiwala collaborated with Wistar’s medicinal chemist Joseph Salvino, Ph.D., professor in The Wistar Institute Cancer Center and a co-senior author on the study, to identify and synthesize novel IspH inhibitor molecules that were able to get inside the bacteria.
The team demonstrated that the IspH inhibitors stimulated the immune system with more potent bacterial killing activity and specificity than current best-in-class antibiotics when tested in vitro on clinical isolates of antibiotic-resistant bacteria, including a wide range of pathogenic gram negative and gram positive bacteria. In preclinical models of gram negative bacterial infection, the bactericidal effects of the IspH inhibitors outperformed traditional pan antibiotics. All compounds tested were shown to be nontoxic to human cells.
“Immune activation represents the second line of attack of the DAIA strategy,” said Kumar Singh, Ph.D., Dotiwala lab postdoctoral fellow and first author of the study.
“We believe this innovative DAIA strategy may represent a potential landmark in the world’s fight against AMR, creating a synergy between the direct killing ability of antibiotics and the natural power of the immune system,” echoed Dotiwala.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
New class of antibiotics
- Semaglutide v. tirzepatide: What to know about popular weight loss and diabetes drugs like Ozempic
Medications like Ozempic and Mounjaro have revolutionized the treatment of Type 2 diabetes and obesity — and they have grown in popularity as well.
- Challenging Old Theories: Innovative Microscopy Exposes New Alzheimer’s Treatment Pathways
Researchers at UC San Diego have utilized advanced imaging techniques to explore the metabolic processes behind Alzheimer's disease, leading to potential new strategies for treatment. Alzheimer's ...
- More than a fifth of young motorists find it ‘acceptable’ to be behind wheel while high on cocaine
Driving while high on cocaine is “acceptable” to more than one in five young drivers, a survey has revealed. A survey for IAM RoadSmart, the charity, found that a “concerning minority” of motorists ...
- FDA approves new antibiotic against UTIs
"The FDA is committed to fostering new antibiotic availability when they prove to be safe and effective, and Pivya will provide an additional treatment option for uncomplicated UTIs," he added.
- What do weight loss drugs mean for a diet industry built on eating less and exercising more?
The world of drug-assisted weight loss also is altering the ambitions of food companies. Sales of SlimFast, a line of meal replacement shakes and snacks sold at supermarkets, have dropped as people ...
Go deeper with Google Headlines on:
New class of antibiotics
[google_news title=”” keyword=”new class of antibiotics” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Drug-resistant bacterial pathogens
- AI Model Shows Promise in Fighting Drug Resistance
As antibiotic resistance continues to pose a formidable challenge, AI-driven solutions offer a beacon of hope in the fight against drug-resistant pathogens.
- Breakthrough Vaccine Shows High Protection Against Drug-Resistant Superbug in Mice
Scientists have developed a vaccine against a notorious drug-resistant superbug, targeting molecules on its surface that are also found on other bacteria and fungi. Although only tested in mice, the ...
- A Vaccine to Fight Antibiotic Resistance
MSU, Harvard Medical School team up to expand vaccine science’s role in the fight against MRSA and other infections ...
- Study suggests spread of drug-resistant bacteria from people to nature
A group of researchers at institutions including Japan's Hokkaido University says a study has found that drug-resistant bacteria may be spreading from human society to aquatic environments and ...
- Antibiotic resistance in babies varies according to mode of birth, prematurity and where they live, says analysis
A meta-analysis of genetic studies analyzing the microbiota (bacteria in the gut) of 1,275 infants from 10 countries finds that cesarean delivery and antibiotic use are driving the increase of ...
Go deeper with Google Headlines on:
Drug-resistant bacterial pathogens
[google_news title=”” keyword=”drug-resistant bacterial pathogens” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]